-
CEO Luke Tanzer talked about the expansion drive as the legacy firm reported a 14.3% RoE for 2023.
-
The market also outperformed various indices including the MSCI World.
-
We explore the first stages of incorporation of GenAI into insurance, alongside the longer-term potential.
-
This year’s analysis of profitability and volatility also includes an alternate view over five years.
-
Transatlantic competition, rising valuations and price undercutting set a challenging scene.
-
In a departure from 2022 trends, fourth-quartile firms grew the slowest of all syndicates in 2023 at 8.1%.
-
-
Work is still to be done on the investor proposition, expenses, and navigating a waning pricing cycle.
-
The executive said Aviva and Fidelis had endorsed the market’s turnaround.
-
The injection will be sufficient to take the platform through its next stage of major development.
-
There is frustration in the market that remediation work has been squandered.
-
Computable binding authority agreement set for April 2025 launch.